Precigen Ownership | Who Owns Precigen?
Precigen Ownership Summary
Precigen is owned by 22.77% institutional investors, 13.73% insiders, and 63.50% retail investors. Patient capital management is the largest institutional shareholder, holding 8.93% of PGEN shares. Patient Opportunity C is the top mutual fund, with 3.96% of its assets in Precigen shares.
PGEN Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Precigen | 22.77% | 13.73% | 63.50% |
| Sector | Healthcare Stocks | 232.01% | 10.74% | -142.75% |
| Industry | Biotech Stocks | 381.47% | 10.55% | -292.02% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Patient capital management | 26.46M | 8.93% | $87.06M |
| Blackrock funding, inc. /de | 15.09M | 5.09% | $63.09M |
| Tang capital management | 12.40M | 4.18% | $40.80M |
| Blackrock | 10.25M | 4.11% | $16.19M |
| Vanguard group | 10.48M | 3.54% | $43.80M |
| State street | 4.49M | 1.51% | $14.77M |
| Geode capital management | 4.46M | 1.51% | $18.65M |
| Iridian asset management llc/ct | 3.60M | 1.21% | $15.05M |
| Morgan stanley | 3.19M | 1.08% | $13.35M |
| Point72 asset management | 2.74M | 0.92% | $9.02M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Iridian asset management llc/ct | 3.60M | 5.54% | $15.05M |
| Patient capital management | 26.46M | 3.48% | $87.06M |
| Tang capital management | 12.40M | 1.57% | $40.80M |
| Diametric capital, lp | 974.23K | 1.19% | $3.21M |
| Boxer capital management | 850.00K | 0.89% | $2.80M |
| Emfo | 519.48K | 0.73% | $820.77K |
| Parkman healthcare partners | 2.10M | 0.72% | $6.91M |
| Lansing street advisors | 547.04K | 0.58% | $2.29M |
| Impala asset management | 165.00K | 0.43% | $689.70K |
| Lexaurum advisors | 666.04K | 0.31% | $2.19M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Tang capital management | 12.40M | 1.57% | 12.40M |
| Patient capital management | 26.46M | 3.48% | 10.19M |
| Blackrock funding, inc. /de | 15.09M | 0.00% | 2.94M |
| Point72 asset management | 2.74M | 0.02% | 2.74M |
| Driehaus capital management | 2.04M | 0.05% | 2.04M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Adage capital partners gp | 846.00K | 0.00% | -10.43M |
| Opaleye management | - | - | -947.50K |
| D. e. shaw | 424.90K | 0.00% | -792.73K |
| Gmt capital | - | - | -668.83K |
| Schonfeld strategic advisors | 856.59K | 0.02% | -581.87K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Tang capital management | 12.40M | 1.57% | 12.40M | $40.80M |
| Point72 asset management | 2.74M | 0.02% | 2.74M | $9.02M |
| Driehaus capital management | 2.04M | 0.05% | 2.04M | $6.72M |
| Boxer capital management | 850.00K | 0.89% | 850.00K | $2.80M |
| Wellington management group llp | 522.18K | 0.00% | 522.18K | $1.72M |
Sold Out
| Holder | Change |
|---|---|
| Capital performance advisors llp | -2.00 |
| True wealth design | -20.00 |
| Financial consulate | -70.00 |
| Us bancorp \de\ | -74.00 |
| Total investment management | -86.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 113 | -35.80% | 67,502,683 | -39.35% | 22 | 1.62% | 69 | -26.60% | 19 | -52.50% |
| Sep 30, 2025 | 170 | 15.65% | 111,283,863 | 41.15% | 37 | 5.31% | 91 | 42.19% | 38 | 15.15% |
| Jun 30, 2025 | 148 | 4.23% | 81,957,215 | 2.59% | 27 | 3.30% | 64 | 6.67% | 34 | -17.07% |
| Mar 31, 2025 | 141 | 6.01% | 79,994,349 | 5.56% | 28 | 3.84% | 58 | -10.77% | 42 | 44.83% |
| Dec 31, 2024 | 69 | -47.73% | 34,834,421 | -53.82% | 12 | 1.41% | 32 | -40.74% | 13 | -58.06% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Patient Opportunity C | 14.02M | 3.96% | -6.48M |
| Vanguard US Total Market Shares ETF | 5.45M | 1.85% | - |
| State Street® SPDR® S&P® Biotech ETF | 6.41M | 1.81% | -34.54K |
| Vanguard Total Stock Mkt Idx Inv | 5.00M | 1.41% | - |
| iShares Russell 2000 ETF | 4.33M | 1.22% | 2.27M |
| Fidelity Small Cap Growth | 2.03M | 0.57% | 1.13M |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.92M | 0.54% | -3.12K |
| Fidelity Small Cap Index | 1.52M | 0.43% | 4.68K |
| Heptagon Driehaus US Micro Cap Eq C$ Acc | 1.41M | 0.40% | -328.57K |
| iShares Russell 2000 Growth ETF | 1.40M | 0.39% | 1.40M |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 22, 2025 | KIRK RANDAL J | Sell | $394.35K | |
| Dec 22, 2025 | KIRK RANDAL J | Sell | $665.96K | |
| Dec 22, 2025 | KIRK RANDAL J | Sell | $4.00M | |
| Dec 22, 2025 | KIRK RANDAL J | Sell | $2.32M | |
| Dec 22, 2025 | KIRK RANDAL J | Sell | $161.89K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | - |
| 2025 Q4 | - | 15 |
| 2025 Q3 | 7 | 5 |
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
PGEN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools